BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20100953)

  • 1. Central institutional review board-facilitated review metrics omit critical components.
    Katz MS; Smith ML
    J Clin Oncol; 2010 Feb; 28(6):e105; author reply e106. PubMed ID: 20100953
    [No Abstract]   [Full Text] [Related]  

  • 2. Financial relationships of institutional review board members.
    Miller FG
    N Engl J Med; 2007 Mar; 356(9):965; author reply 965. PubMed ID: 17329710
    [No Abstract]   [Full Text] [Related]  

  • 3. Costs and benefits of the national cancer institute central institutional review board.
    Wagner TH; Murray C; Goldberg J; Adler JM; Abrams J
    J Clin Oncol; 2010 Feb; 28(4):662-6. PubMed ID: 19841324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The controversy surrounding central institutional review boards.
    Savage TA; Mukherjee D
    PM R; 2010 Jan; 2(1):57-61; discussion 62-3. PubMed ID: 20129514
    [No Abstract]   [Full Text] [Related]  

  • 5. The costs of institutional review boards.
    Bhat S; Hegde TT
    N Engl J Med; 2005 Jul; 353(3):315-7; author reply 315-7. PubMed ID: 16038060
    [No Abstract]   [Full Text] [Related]  

  • 6. Barriers to conducting clinical research in reproductive medicine: United States of America.
    Legro RS
    Fertil Steril; 2011 Oct; 96(4):817-9. PubMed ID: 21961918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do research ethics committees identify process errors in applications for ethical approval?
    Angell E; Dixon-Woods M
    J Med Ethics; 2009 Feb; 35(2):130-2. PubMed ID: 19181888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs of institutional review boards.
    Dickler HB; Korn D
    N Engl J Med; 2005 Jul; 353(3):315-7; author reply 315-7. PubMed ID: 16034023
    [No Abstract]   [Full Text] [Related]  

  • 9. Researchers facing increasing costs for clinical research, with few solutions.
    Erdmann J
    J Natl Cancer Inst; 2005 Oct; 97(20):1492-4. PubMed ID: 16234558
    [No Abstract]   [Full Text] [Related]  

  • 10. Research ethics committee: getting started.
    Macpherson CC
    West Indian Med J; 2001 Sep; 50(3):186-8. PubMed ID: 11769020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: refusing to give up on forensic research.
    Young JL
    J Am Acad Psychiatry Law; 2005; 33(3):368-70. PubMed ID: 16186202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in institutional review board responses to a standard, observational, pediatric research protocol.
    Mansbach J; Acholonu U; Clark S; Camargo CA
    Acad Emerg Med; 2007 Apr; 14(4):377-80. PubMed ID: 17312334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontario Cancer Research Ethics Board: lessons learned from developing a multicenter regional institutional review board.
    Saginur R; Dent SF; Schwartz L; Heslegrave R; Stacey S; Manzo J
    J Clin Oncol; 2008 Mar; 26(9):1479-82. PubMed ID: 18349399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deputizing institutional review boards to police (audit?) biomedical research.
    Noah L
    J Leg Med; 2004 Sep; 25(3):267-93; discussion 295-301. PubMed ID: 15620048
    [No Abstract]   [Full Text] [Related]  

  • 15. United States military contributions to the National Cancer Institute.
    Sarvis JA; Thompson IM
    Urol Oncol; 2009; 27(5):558-61. PubMed ID: 19720303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in the costs of institutional review board oversight.
    Byrne MM; Speckman J; Getz K; Sugarman J
    Acad Med; 2006 Aug; 81(8):708-12. PubMed ID: 16868423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Society for Academic Emergency Medicine position on ethical relationships with the biomedical industry.
    Schears RM; Watters A; Schmidt TA; Marco CA; Larkin GL; Marshall JP; Mason JD; McBeth BD; Mello MJ;
    Acad Emerg Med; 2007 Feb; 14(2):179-81. PubMed ID: 17185294
    [No Abstract]   [Full Text] [Related]  

  • 18. Sharing scientific data III: planning and the research proposal.
    Flournoy N; Hearne LB
    IRB; 1990; 12(3):6-9. PubMed ID: 11651388
    [No Abstract]   [Full Text] [Related]  

  • 19. The institutional review board and you.
    Neff MJ
    Respir Care; 2008 Oct; 53(10):1324. PubMed ID: 18811994
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.